

Speaker: Evangelos Spyridakis, MD
Objectives:
At the conclusion, the participant should be able to:
1) DESCRIBE the pathogenesis of Neuroblastoma; 2) SUMMARIZE the clinical manifestations of Neuroblastoma; 3) DISCUSS the diagnosis of Neuroblastoma; 4) DESCRIBE the advances in therapy of Neuroblastoma.
Questions and answers will allow for audience participation.
© MeCop 2025. All rights reserved